Refer A Patient

When to Refer to The Mood Center

Patient Has Not Responded to 2 or More Antidepressant Trials

Treatment Option 1:

(esketamine nasal spray)

FDA-approved for treatment-resistant depression and MDD with suicidal ideation
Concurrent antidepressant use not required

In-office administration
Insurance-covered for qualifying patients

Treatment Option 2:

(Transcranial Magnetic Stimulation)

FDA-cleared for depression and OCD
Non-invasive and medication-free
Insurance-covered for qualifying patients

Prefer a Traditional Referral?

To refer a patient, please fill out the form on this page. This website operates on a secure server (SSL protected) and has SiteLock web security so all information you provide is encrypted, HIPAA compliant, and safe. We never share your information with third parties.